Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Foxo4-dri

Proxofim, FOXO4 D-Retro-Inverso peptide

A synthetic D-retro-inverso peptide that disrupts FOXO4-p53 interaction, inducing selective apoptosis in senescent cells to reverse aging effects.

Molecular Profile
Formula C228H388N86O64
Mol. Weight 5358 g/mol
Sequence Gly-Glu-Pro-Pro...
Route
Intraperitoneal (IP, animal)
5 mg/kg
INT
Subcutaneous (SC)
300-500 mcg
SUB

How It Works

How It Works: FOXO4-DRI acts as a senolytic by blocking the interaction between FOXO4 and p53 in senescent cells, enabling p53-mediated apoptosis and tissue rejuvenation.

  • Competes with FOXO4 for p53 binding, freeing p53 to activate apoptotic pathways.
  • Selectively induces cell death in senescent cells with elevated FOXO4 levels.
  • Reduces senescence-associated secretory phenotype (SASP) and inflammation.
  • Promotes restoration of tissue homeostasis and function.

Latest Studies

Utility 3
pubmed Jul 1, 2025

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI.

Bourgeois. Benjamin B; Spreitzer. Emil E; Platero-Rochart. Daniel D; Paar. Margr...

Scientists discovered that the anti‑aging peptide FOXO4‑DRI sticks to a part of the p53 protein that’s usually floppy, and this binding helps kill old, senescent cells. The peptide works best when p53 is phosphorylated, and the study maps out exactly how the two molecules fit together.

Utility 2
pubmed Feb 24, 2025

FOXO4-DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53-serine 15 phosphorylation.

Kong. Yu-Xiang YX; Li. Zhi-Shuai ZS; Liu. Yuan-Bo YB; Pan. Bo B; Fu. Xin X; Xiao...

Researchers found that a synthetic peptide called FOXO4-DRI can make scar‑forming cells (keloid fibroblasts) that are stuck in a senescent, aging‑like state die by pushing a key protein (p53) out of the cell nucleus. This reduces the number of stubborn scar cells in lab models, suggesting the peptide could help treat hard‑to‑heal scars.

Utility 2
pubmed Jul 19, 2024

FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells.

Li. Yanqing Y; Zhang. Chi C; Cheng. Haicheng H; Lv. LinYan L; Zhu. Xinning X; Ma...

A study in old mice found that a short peptide called FOXO4-DRI can kill aging Leydig cells in the testicles, lower the harmful chemicals they release, and help sperm production improve. Treated mice had better sperm quality and more active spermatogenesis, suggesting the peptide might counter age‑related male fertility loss, but the work is still limited to animal experiments.

Browse All Studies